Cargando…

5% lidocaine medicated plaster double effect in a case of orofacial localized neuropathic pain

Localized neuropathic pain (LNP) is a type of neuropathic pain that is characterized by “consistent and limited area(s) of maximum pain associated with negative or positive sensory signs and/or spontaneous symptoms characteristic of neuropathic pain”. This definition encompasses a huge number of neu...

Descripción completa

Detalles Bibliográficos
Autores principales:	Casale, Roberto, Romanenko, Yuriy, Allegri, Massimo
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove Medical Press 2014
Materias:	Case Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4247146/ https://www.ncbi.nlm.nih.gov/pubmed/25473307 http://dx.doi.org/10.2147/JPR.S70317

Ejemplares similares

Reduction of painful area as new possible therapeutic target in post-herpetic neuropathic pain treated with 5% lidocaine medicated plaster: a case series
por: Casale, Roberto, et al.
Publicado: (2014)

Treatment of localized neuropathic pain after disk herniation with 5% lidocaine medicated plaster
por: Likar, Rudolf, et al.
Publicado: (2012)

Treatment of localized post-traumatic neuropathic pain in scars with 5% lidocaine medicated plaster
por: Correa-Illanes, Gerardo, et al.
Publicado: (2010)

Building a diagnostic algorithm on localized neuropathic pain (LNP) and targeted topical treatment: focus on 5% lidocaine-medicated plaster
por: Casale, Roberto, et al.
Publicado: (2014)

The 5% Lidocaine-Medicated Plaster: Its Inclusion in International Treatment Guidelines for Treating Localized Neuropathic Pain, and Clinical Evidence Supporting its Use
por: Baron, Ralf, et al.
Publicado: (2016)

Use of 5% lidocaine medicated plaster to treat localized neuropathic pain secondary to traumatic injury of peripheral nerves
por: Correa-Illanes, Gerardo, et al.
Publicado: (2012)

The topical 5% lidocaine medicated plaster in localized neuropathic pain: a reappraisal of the clinical evidence
por: de León-Casasola, Oscar A, et al.
Publicado: (2016)

Can treatment success with 5% lidocaine medicated plaster be predicted in cancer pain with neuropathic components or trigeminal neuropathic pain?
por: Kern, Kai-Uwe, et al.
Publicado: (2013)

Treatment of localized neuropathic pain of different etiologies with the 5% lidocaine medicated plaster – a case series
por: Likar, Rudolf, et al.
Publicado: (2014)

5% Lidocaine-medicated plaster for the treatment of chronic peripheral neuropathic pain: complex regional pain syndrome and other neuropathic conditions
por: Calderón, Enrique, et al.
Publicado: (2016)

Outcome predictors for treatment success with 5% lidocaine medicated plaster in low back pain with neuropathic components and neuropathic pain after surgical and nonsurgical trauma
por: Nicolaou, Andrew, et al.
Publicado: (2011)

Pregabalin, the lidocaine plaster and duloxetine in patients with refractory neuropathic pain: a systematic review
por: Plested, Melanie, et al.
Publicado: (2010)

Lidocaine 5% Patch in Localized Neuropathic Pain
por: Nair, Abhijit S, et al.
Publicado: (2019)

Health economic evidence of 5% lidocaine medicated plaster in post-herpetic neuralgia
por: Liedgens, Hiltrud, et al.
Publicado: (2013)

Comparative Benefit–Risk Assessment for Lidocaine 700 mg Medicated Plaster and Pregabalin in Peripheral Neuropathic Pain Following a Structured Framework Approach
por: Sabatschus, Ingo, et al.
Publicado: (2021)

Topical Treatments for Localized Neuropathic Pain
por: Casale, Roberto, et al.
Publicado: (2017)

5% Lidocaine Medicated Plaster for the Treatment of Postherpetic Neuralgia: A Review of the Clinical Safety and Tolerability
por: Navez, Marie Louise, et al.
Publicado: (2015)

A Review on Autophagy in Orofacial Neuropathic Pain
por: Shrivastava, Mayank, et al.
Publicado: (2022)

Open-Label Adhesion Performance Studies of a New Lidocaine Topical System 1.8% versus Lidocaine Patches 5% and Lidocaine Medicated Plaster 5% in Healthy Subjects
por: Gudin, Jeffrey, et al.
Publicado: (2021)

Lidocaine 5% patch for localized neuropathic pain: progress for the patient, a new approach for the physician
por: Hans, Guy, et al.
Publicado: (2010)

The use of 5% lidocaine medicated plaster for acute postoperative pain after gynecological surgery: A pilot randomized controlled feasibility trial
por: Lau, Lydia LN, et al.
Publicado: (2018)

Orofacial Neuropathic Pain-Basic Research and Their Clinical Relevancies
por: Shinoda, Masamichi, et al.
Publicado: (2021)

Design of Liposomal Lidocaine/Cannabidiol Fixed Combinations for Local Neuropathic Pain Treatment
por: Franzè, Silvia, et al.
Publicado: (2022)

Radiation-induced neuropathic pain successfully treated with systemic lidocaine administration
por: Doo, A Ram, et al.
Publicado: (2018)

Local hyperexcitability of C-nociceptors may predict responsiveness to topical lidocaine in neuropathic pain
por: Landmann, Gunther, et al.
Publicado: (2022)

Behavioral testing in rodent models of orofacial neuropathic and inflammatory pain
por: Krzyzanowska, Agnieszka, et al.
Publicado: (2012)

Painful diabetic peripheral neuropathy: real-world comparison between topical treatment with lidocaine 700 mg medicated plaster and oral treatments
por: Überall, Michael, et al.
Publicado: (2022)

Walking with Neuropathic Pain: Paradoxical Shift from Burden to Support?
por: Kopsky, David J., et al.
Publicado: (2015)

Histone deacetylase inhibitors prevent persistent hypersensitivity in an orofacial neuropathic pain model
por: Danaher, Robert J, et al.
Publicado: (2018)

In search of a rodent model of placebo analgesia in chronic orofacial neuropathic pain
por: Akintola, Titilola, et al.
Publicado: (2019)

Effect of Intravenous Lidocaine on the Neuropathic Pain of Failed Back Surgery Syndrome
por: Park, Chan Hong, et al.
Publicado: (2012)

Transdermal Lidocaine and Ketamine for Neuropathic Pain: A Study of Effectiveness and Tolerability
por: Tam, Emily, et al.
Publicado: (2012)

Treatment of Neuropathic Pain with the Capsaicin 8% Patch: Is Pretreatment with Lidocaine Necessary?
por: Kern, Kai-Uwe, et al.
Publicado: (2014)

Neuron–Glia Crosstalk and Neuropathic Pain: Involvement in the Modulation of Motor Activity in the Orofacial Region
por: Hossain, Mohammad Zakir, et al.
Publicado: (2017)

Altered regional brain T2 relaxation times in individuals with chronic orofacial neuropathic pain
por: Alshelh, Z., et al.
Publicado: (2018)

Is Botulinum Toxin Effective in Treating Orofacial Neuropathic Pain Disorders? A Systematic Review
por: Val, Matteo, et al.
Publicado: (2023)

Predictive Value of Lidocaine for Treatment Success of Oxcarbazepine in Patients with Neuropathic Pain Syndrome
por: Schipper, Sivan, et al.
Publicado: (2013)

Chemokine CXCL13 mediates orofacial neuropathic pain via CXCR5/ERK pathway in the trigeminal ganglion of mice
por: Zhang, Qian, et al.
Publicado: (2016)

Orofacial Pains
por: Rakhshan, Vahid, et al.
Publicado: (2017)

Orofacial neuropathic pain mouse model induced by Trigeminal Inflammatory Compression (TIC) of the infraorbital nerve
por: Ma, Fei, et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_u3v7mu0ehjgasovm6712ag2t8d